Nevro Long Term Debt vs Total Revenue Analysis

NVRO Stock

USD 4.60 0.02 0.44%

Nevro Corp financial indicator trend analysis is infinitely more than just investigating Nevro Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nevro Corp is a good investment. Please check the relationship between Nevro Corp Long Term Debt and its Total Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Long Term Debt vs Total Revenue

Long Term Debt vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nevro Corp Long Term Debt account and Total Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Nevro Corp's Long Term Debt and Total Revenue is 0.97. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Nevro Corp, assuming nothing else is changed. The correlation between historical values of Nevro Corp's Long Term Debt and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Nevro Corp are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Long Term Debt i.e., Nevro Corp's Long Term Debt and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that Nevro Corp has held for over one year. Long-term debt appears on Nevro Corp balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Nevro Corp balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Total Revenue

Total revenue comprises all receipts Nevro Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Nevro Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nevro Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.At this time, Nevro Corp's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 29th of November 2024, Enterprise Value is likely to grow to about 1.5 B, while Selling General Administrative is likely to drop about 215.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	266.0M	276.4M	290.1M	191.8M
Total Revenue	386.9M	406.4M	425.2M	280.2M

Gross Profit Total Revenue

Nevro Corp fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.91	0.86	0.97	0.42	0.87	0.86	-0.86	0.89	0.68	0.63	0.6	0.61	0.97	0.93	0.92	0.94	0.91	0.91	0.91	0.87	0.96	0.98	0.7	1.0	0.92
Other Current Liab	0.91		0.67	0.83	0.42	0.9	0.77	-0.86	0.84	0.7	0.69	0.81	0.52	0.79	0.98	0.87	0.92	0.71	0.97	0.95	0.93	0.93	0.94	0.74	0.89	0.86
Total Current Liabilities	0.86	0.67		0.81	0.29	0.71	0.9	-0.64	0.64	0.38	0.44	0.41	0.84	0.92	0.7	0.64	0.68	0.93	0.63	0.61	0.66	0.75	0.86	0.52	0.87	0.65
Total Stockholder Equity	0.97	0.83	0.81		0.41	0.79	0.76	-0.8	0.91	0.71	0.56	0.51	0.56	0.97	0.86	0.95	0.93	0.91	0.83	0.88	0.78	0.93	0.91	0.63	0.98	0.95
Other Liab	0.42	0.42	0.29	0.41		0.57	0.38	-0.52	0.59	0.03	0.28	0.21	0.15	0.4	0.39	0.38	0.42	0.45	0.42	0.38	0.13	0.51	0.41	0.36	0.41	0.39
Property Plant And Equipment Net	0.87	0.9	0.71	0.79	0.57		0.73	-0.91	0.81	0.66	0.69	0.67	0.53	0.79	0.85	0.77	0.82	0.72	0.88	0.79	0.85	0.93	0.89	0.78	0.84	0.76
Net Debt	0.86	0.77	0.9	0.76	0.38	0.73		-0.66	0.61	0.26	0.47	0.52	0.77	0.87	0.81	0.64	0.69	0.91	0.77	0.68	0.71	0.75	0.9	0.54	0.86	0.64
Retained Earnings	-0.86	-0.86	-0.64	-0.8	-0.52	-0.91	-0.66		-0.82	-0.7	-0.89	-0.54	-0.29	-0.77	-0.82	-0.79	-0.82	-0.69	-0.88	-0.81	-0.81	-0.92	-0.86	-0.94	-0.83	-0.78
Accounts Payable	0.89	0.84	0.64	0.91	0.59	0.81	0.61	-0.82		0.72	0.55	0.54	0.4	0.83	0.85	0.88	0.95	0.75	0.82	0.9	0.72	0.93	0.83	0.62	0.89	0.89
Cash	0.68	0.7	0.38	0.71	0.03	0.66	0.26	-0.7	0.72		0.59	0.49	0.15	0.57	0.67	0.77	0.78	0.39	0.7	0.77	0.8	0.77	0.63	0.62	0.66	0.75
Non Current Assets Total	0.63	0.69	0.44	0.56	0.28	0.69	0.47	-0.89	0.55	0.59		0.51	0.08	0.52	0.62	0.59	0.6	0.43	0.71	0.64	0.69	0.69	0.67	0.99	0.58	0.57
Non Currrent Assets Other	0.6	0.81	0.41	0.51	0.21	0.67	0.52	-0.54	0.54	0.49	0.51		0.54	0.46	0.78	0.64	0.68	0.39	0.7	0.71	0.75	0.6	0.65	0.51	0.58	0.64
Other Assets	0.61	0.52	0.84	0.56	0.15	0.53	0.77	-0.29	0.4	0.15	0.08	0.54		0.68	0.56	0.44	0.48	0.73	0.4	0.39	0.5	0.47	0.63	0.15	0.64	0.46
Cash And Short Term Investments	0.97	0.79	0.92	0.97	0.4	0.79	0.87	-0.77	0.83	0.57	0.52	0.46	0.68		0.82	0.86	0.86	0.98	0.79	0.79	0.75	0.89	0.93	0.6	0.98	0.87
Net Receivables	0.93	0.98	0.7	0.86	0.39	0.85	0.81	-0.82	0.85	0.67	0.62	0.78	0.56	0.82		0.86	0.94	0.76	0.96	0.95	0.92	0.92	0.94	0.68	0.92	0.86
Common Stock Total Equity	0.92	0.87	0.64	0.95	0.38	0.77	0.64	-0.79	0.88	0.77	0.59	0.64	0.44	0.86	0.86		0.94	0.77	0.87	0.91	0.81	0.9	0.86	0.64	0.91	1.0
Common Stock Shares Outstanding	0.94	0.92	0.68	0.93	0.42	0.82	0.69	-0.82	0.95	0.78	0.6	0.68	0.48	0.86	0.94	0.94		0.76	0.91	0.98	0.86	0.95	0.9	0.66	0.93	0.94
Short Term Investments	0.91	0.71	0.93	0.91	0.45	0.72	0.91	-0.69	0.75	0.39	0.43	0.39	0.73	0.98	0.76	0.77	0.76		0.71	0.7	0.64	0.8	0.88	0.51	0.93	0.78
Non Current Liabilities Total	0.91	0.97	0.63	0.83	0.42	0.88	0.77	-0.88	0.82	0.7	0.71	0.7	0.4	0.79	0.96	0.87	0.91	0.71		0.95	0.92	0.94	0.94	0.76	0.89	0.85
Inventory	0.91	0.95	0.61	0.88	0.38	0.79	0.68	-0.81	0.9	0.77	0.64	0.71	0.39	0.79	0.95	0.91	0.98	0.7	0.95		0.88	0.93	0.9	0.68	0.9	0.9
Other Current Assets	0.87	0.93	0.66	0.78	0.13	0.85	0.71	-0.81	0.72	0.8	0.69	0.75	0.5	0.75	0.92	0.81	0.86	0.64	0.92	0.88		0.87	0.9	0.73	0.84	0.8
Other Stockholder Equity	0.96	0.93	0.75	0.93	0.51	0.93	0.75	-0.92	0.93	0.77	0.69	0.6	0.47	0.89	0.92	0.9	0.95	0.8	0.94	0.93	0.87		0.95	0.77	0.94	0.89
Total Liab	0.98	0.94	0.86	0.91	0.41	0.89	0.9	-0.86	0.83	0.63	0.67	0.65	0.63	0.93	0.94	0.86	0.9	0.88	0.94	0.9	0.9	0.95		0.73	0.97	0.85
Property Plant And Equipment Gross	0.7	0.74	0.52	0.63	0.36	0.78	0.54	-0.94	0.62	0.62	0.99	0.51	0.15	0.6	0.68	0.64	0.66	0.51	0.76	0.68	0.73	0.77	0.73		0.66	0.62
Total Current Assets	1.0	0.89	0.87	0.98	0.41	0.84	0.86	-0.83	0.89	0.66	0.58	0.58	0.64	0.98	0.92	0.91	0.93	0.93	0.89	0.9	0.84	0.94	0.97	0.66		0.91
Common Stock	0.92	0.86	0.65	0.95	0.39	0.76	0.64	-0.78	0.89	0.75	0.57	0.64	0.46	0.87	0.86	1.0	0.94	0.78	0.85	0.9	0.8	0.89	0.85	0.62	0.91

Click cells to compare fundamentals

Nevro Corp Account Relationship Matchups

Nevro Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	469.6M	789.4M	574.5M	602.4M	635.7M	461.8M
Other Current Liab	54.6M	42.2M	44.5M	45.3M	53.7M	34.2M
Total Current Liabilities	70.6M	239.2M	82.2M	79.2M	83.4M	71.3M
Total Stockholder Equity	216.4M	388.5M	303.6M	323.9M	293.1M	255.5M
Other Liab	1.9M	3.3M	22.0M	2.2M	2.5M	3.6M
Property Plant And Equipment Net	33.3M	31.7M	38.2M	35.7M	33.5M	19.1M
Net Debt	115.4M	282.6M	132.0M	76.8M	117.6M	85.6M
Retained Earnings	(409.8M)	(492.8M)	(624.2M)	(607.2M)	(699.4M)	(664.4M)
Accounts Payable	16.0M	23.1M	32.0M	26.8M	22.5M	19.3M
Cash	65.4M	44.6M	34.7M	120.4M	104.2M	58.2M
Non Current Assets Total	47.6M	36.3M	43.3M	39.5M	104.8M	110.0M
Non Currrent Assets Other	13.3M	4.0M	4.5M	3.2M	5.8M	4.5M
Other Assets	14.3M	22.8M	5.1M	3.8M	1.0	0.95
Cash And Short Term Investments	237.8M	588.0M	362.0M	374.4M	322.7M	289.0M
Net Receivables	82.8M	77.7M	70.5M	78.9M	79.4M	57.9M
Common Stock Shares Outstanding	30.8M	33.7M	34.8M	35.5M	36.0M	26.7M
Short Term Investments	172.4M	543.4M	327.3M	254.0M	218.5M	230.8M
Liabilities And Stockholders Equity	469.6M	789.4M	574.5M	602.4M	635.7M	461.8M
Non Current Liabilities Total	182.7M	161.8M	188.7M	199.3M	259.2M	135.1M
Inventory	91.6M	83.3M	93.5M	99.6M	118.7M	78.7M
Other Current Assets	9.8M	8.3M	5.2M	10.0M	10.1M	6.7M
Other Stockholder Equity	626.4M	880.7M	928.1M	934.1M	992.8M	588.4M
Total Liab	253.3M	401.0M	270.9M	278.5M	342.6M	206.3M
Property Plant And Equipment Gross	33.3M	31.7M	38.2M	35.7M	69.2M	72.6M
Total Current Assets	422.1M	753.1M	531.2M	562.9M	530.9M	432.0M
Accumulated Other Comprehensive Income	(313K)	598K	(364K)	(3.1M)	(243K)	(255.2K)
Property Plant Equipment	11.8M	13.5M	20.7M	22.3M	25.6M	26.9M
Short Long Term Debt Total	180.7M	327.2M	166.7M	197.2M	221.8M	172.5M
Net Tangible Assets	216.4M	388.5M	303.6M	323.9M	372.5M	291.2M
Long Term Debt	160.3M	141.8M	151.3M	186.9M	211.5M	145.9M
Retained Earnings Total Equity	(409.8M)	(492.8M)	(624.2M)	(607.2M)	(546.5M)	(573.8M)
Long Term Debt Total	160.3M	141.8M	151.3M	186.9M	214.9M	136.3M
Capital Surpluse	626.4M	880.7M	928.1M	934.1M	1.1B	686.8M
Non Current Liabilities Other	22.4M	20.0M	37.4M	12.5M	43.1M	45.2M
Net Invested Capital	376.7M	699.0M	454.9M	510.7M	504.6M	524.5M
Net Working Capital	351.4M	513.9M	449.0M	483.7M	447.5M	473.0M

Pair Trading with Nevro Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against Nevro Stock

0.67	ELMD	Electromed	Pair Corr
0.54	DOCS	Doximity Sell-off Trend	Pair Corr
0.5	DXCM	DexCom Inc	Pair Corr
0.49	OM	Outset Medical	Pair Corr
0.45	VNRX	Volitionrx	Pair Corr

The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.

The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:

How To Invest In Nevro

Details

Is Nevro Stock a good investment?

Details

What is Nevro Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.87)

Revenue Per Share

11.404

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.09)

Return On Equity

(0.25)

The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nevro Long Term Debt vs Total Revenue Analysis

Long Term Debt vs Total Revenue

Long Term Debt vs Total Revenue Correlation Analysis

Correlation Coefficient

Long Term Debt

Total Revenue

Nevro Corp fundamental ratios Correlations

Nevro Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nevro Corp fundamental ratios Accounts

Pair Trading with Nevro Corp

Moving against Nevro Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Common Stock	+ 1.0	Common Stock Total Equity
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Liab	+ 0.98	Total Assets
Net Receivables	+ 0.98	Other Current Liab
Total Current Assets	+ 0.98	Total Stockholder Equity

Property Plant And Equipment Gross	- 0.94	Retained Earnings
Other Stockholder Equity	- 0.92	Retained Earnings
Retained Earnings	- 0.91	Property Plant And Equipment Net
Non Current Assets Total	- 0.89	Retained Earnings
Non Current Liabilities Total	- 0.88	Retained Earnings
Total Liab	- 0.86	Retained Earnings